EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is PTEN rs397510595 an Unexpected Guardian in Canine Mammary Neoplasia?

Ana Canadas-Sousa iD, Marta Santos iD, Patrícia Dias-Pereira iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ana Canadas-Sousa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Mammary Neoplasms, Animal, Polymorphism, Single Nucleotide, Dog Diseases. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite steps having been taken to study the influence of genetic polymorphisms in canine mammary neoplasia, the knowledge of their relevance is still incipient compared to the knowledge of human breast cancer. Among tumor suppressor genes, PTEN plays a pivotal role in carcinogenesis; however, the contribution of its constitutional variants to the biology of canine mammary neoplasia remains poorly understood. This observational study assessed the association between PTEN SNPs rs397510595 and rs397513087, genotyped from peripheral blood, and the clinicopathological features, including survival, in a cohort of 206 female dogs with mammary neoplasia. The minor A allele of rs397510595 was present in 17.5% of the population. Carriers of the variant allele were more frequently diagnosed at a late age ≥ 11 years, displayed a complete absence of vascular invasion, and exhibited significantly longer overall survival (mean 22.2 vs. 19.5 months). The SNP rs397513087 did not show a significant association with clinicopathological features or survival. Our data suggests that SNP rs397510595 of the PTEN gene is a putative protective factor for developing canine mammary neoplasia at an early age and might be used as a biomarker for prognostic assessment in dogs with malignant mammary neoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseMammary Neoplasms, AnimalPolymorphism, Single NucleotideDog DiseasesAnimalsDogsFemaleGenetic Predisposition to DiseaseAllelesGenotypePrognosis

Stichwörter der Autor:innen

PTEN geneSNPcanine mammary neoplasiasurvivalvascular invasion

Substanzen

PTEN Phosphohydrolase

Autor:innen und Institutionen

  • Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.
  • Associated Laboratory for Green Chemistry (LAQV), REQUIMTE, University of Porto, 4051-401 Porto, Portugal.
  • Vasco da Gama Research Centre (CIVG), Department of Veterinary Sciences, Vasco da Gama University School (EUVG), 3020-210 Coimbra, Portugal.
  • Cytology and Hematology Diagnostic Services, Laboratory of Histology and Embryology, Department of Microscopy, ICBAS, University of Porto, 4050-313 Porto, Portugal.
  • Oncology Research, UMIB-Unit for Multidisciplinary Research in Biomedicine, ICBAS, University of Porto, 4050-313 Porto, Portugal.

ORCID-Profile: Ana Canadas-Sousa, Marta Santos, Patrícia Dias-Pereira

Zitieren

APA

Canadas-Sousa, A., Santos, M., & Dias-Pereira, P. (2025). Is PTEN rs397510595 an Unexpected Guardian in Canine Mammary Neoplasia?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110654

Vancouver

Canadas-Sousa A, Santos M, Dias-Pereira P. Is PTEN rs397510595 an Unexpected Guardian in Canine Mammary Neoplasia?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110654

BibTeX
@article{CanadasSousa2025,
  author = {Canadas-Sousa, Ana and Santos, Marta and Dias-Pereira, Patrícia},
  title = {Is PTEN rs397510595 an Unexpected Guardian in Canine Mammary Neoplasia?},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110654}
}
Kostenlos starten →